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Edited by Masayuki MiyasakaAbstract The oxidoreductase ERp57 is a component of the ma-
jor histocompatibility complex (MHC) class I peptide-loading
complex. ERp57 can interact directly with MHC class I mole-
cules, however, little is known about which of the cysteine resi-
dues within the MHC class I molecule are relevant to this
interaction. MHC class I molecules possess conserved disulﬁde
bonds between cysteines 101–164, and 203–259 in the peptide-
binding and a3 domain, respectively. By studying a series of mu-
tants of these conserved residues, we demonstrate that ERp57
predominantly associates with cysteine residues in the peptide-
binding domain, thus indicating ERp57 has direct access to the
peptide-binding groove of MHC class I molecules during assem-
bly.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Major histocompatibility complex (MHC) class I molecules
bind and present short peptides to CD8+ T lymphocytes,
allowing the detection and elimination of infected cells. During
assembly in the endoplasmic reticulum (ER), MHC class I
molecules interact initially with calnexin and BiP [1,2], before
forming the peptide-loading complex (PLC), which contains
MHC class I molecules, calreticulin, tapasin, ERp57, protein
disulﬁde isomerase (PDI) and TAP [3–10]. Within the PLC,
class I molecules acquire an optimal peptide subset [11,12].
Disulﬁde-bonded intermediates between the MHC class I
heavy chain and ERp57, and also between MHC class I and
PDI have been reported [9,13,14], potentially representing
transient intermediates which would be expected to form dur-
ing attempts to correctly fold MHC class I molecules. In the
case of PDI recent data suggest that it directly controls the oxi-
dation of the peptide-groove disulﬁde bond between Cys101Abbreviations: PDI, protein disulﬁde isomerase; MHC, major histo-
compatibility complex; PLC, peptide-loading complex
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doi:10.1016/j.febslet.2007.04.034and Cys164 of MHC class I molecules within the PLC, thereby
also regulating peptide optimisation [9].
In contrast, the function of ERp57 within the PLC still re-
mains unclear. In ERp57-deﬁcient B cells there is a lack of
optimal peptide loading and an absence of MHC class I mol-
ecules within the PLC [15]. Furthermore, in cells expressing
low levels of ERp57 by RNA interference the initial folding
events of MHC class I in the ER are delayed [16].
To date it has not been determined which of the cysteine res-
idues within MHC class I heavy chains interact with ERp57
during the early events in assembly. We have studied a series
of mutant HLA-A*0201 molecules in which the conserved cys-
teine residues that contribute to intrachain disulﬁde bonds
have been replaced with serine residues. Our data indicate that
the cysteine residues in the peptide-binding groove interact
with ERp57 during the assembly of MHC class I molecules.2. Materials and methods
2.1. Cell lines and DNA
The rat C58 thymoma [17] and human .220.B8 (a gift from P. Leh-
ner, University of Cambridge, UK) cell lines were maintained in RPMI
1640 supplemented with 5% FCS. The single cysteine mutant C58
transfectants have been described previously [18]. All constructs con-
tain a C-terminal v5 epitope tag to aid detection. The double cysteine
mutants in vector pCR3 (Invitrogen) were generated using Quick-
change (Stratagene) methodology and sequenced to conﬁrm mutagen-
esis. C58 cells were transfected by electroporation (180 V, 975 lF,
Biorad Genepulser) and selected in medium containing 1 mg/ml G418.2.2. Antibodies
Monoclonal antibodies (mAbs) and antisera used were as follows:
pK (anti-V5 tag, present on the C-terminus of HLA-A*0201) is re-
ferred to as anti-MHC I heavy chain in the text and ﬁgures for simplic-
ity, HC10 (recognising partially folded HLA-B molecules), BB7.2
(anti-HLA-A2), anti-calnexin antiserum (a gift from D. Williams, Tor-
onto, Canada), anti-ERp57 antiserum (a gift from N. Bulleid, Man-
chester, UK), anti-BiP antiserum (Stressgen, SPA-826).
2.3. Immunoprecipitations and immunoblotting
Cells were pretreated with 20 mM N-ethylmaleimide (NEM, Sigma)
on ice for 15 min and lysed in 1% Nonidet P-40 lysis buﬀer (1% v/v
NP40, 150 mM NaCl, 10 mM Tris pH 7.5, 1 mM PMSF, and 10 mM
NEM). Protein A-Sepharose precleared lysates were immunoprecipi-
tated with anti-MHC class I heavy chain mAb. Washed beads were
resuspended in non-reducing sample buﬀer and analysed on 8% SDS–
PAGE gels. Immunoblots were probed with the indicated mAb or anti-
serum at 1:10000 dilution in PBS containing 0.1% Tween 20 (Sigma),
followed by HRP conjugated anti-mouse or rabbit IgG antisera asblished by Elsevier B.V. All rights reserved.
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West, Perbio). Pulse-chase experiments were performed as previously
described [19]. Brieﬂy 5 · 106 cells were labelled with 3.7 Mbq Trans
label (ICN) for 15 min, and chased for the indicated times in normal
medium. Samples were lysed and immunoprecipitated as above, then
digested with 1 mU endoglycosidase H (Roche) for 1 h at 37 C. Re-
duced samples were analysed by SDS–PAGE, and autoradiography.
2.4. Flow cytometry
Cells, in PBS supplemented with 1% FCS, were stained with anti-
bodies for 30 min at 4 C. After washing, cells were stained with FITC
conjugated anti-mouse IgG, rewashed and analysed using Cellquest
software on a Facscan cytometer (Becton Dickinson).3. Results
3.1. Assembly and cell surface expression in the absence of
conserved cysteine residues
We have previously reported a disulﬁde-bonded intermedi-
ate between ERp57 and MHC class I [14]. To determine which
of the conserved cysteine residues in MHC class I moleculesFig. 1. Lack of conserved cysteines can be compensated for by incubation at r
MHC class I molecules that form disulﬁde bridges. (B) C58 rat thymoma ce
cytometry using mAb BB7.2. Filled curve in the top panel: second stage FITC
small panels indicates BB7.2 staining. (C) Pulse-chase analysis. MHC class I
and samples digested with or without endo H. Endo H sensitive (-s) and resis
for 16 h at 26 C, lysed and MHC class I immunoprecipitated. (E) The indica
by ﬂow cytometry using mAb BB7.2.are responsible for this interaction we have studied a series
of mutants wherein the conserved cysteine residues at positions
101, 164, 203 and 259 (Fig. 1A) of the HLA-A2 heavy chain
have been mutated to serine. The mutants were C-terminally
epitope-tagged to permit isolation of a non-conformational
dependent pool of MHC class I molecules, and were expressed
as stable transfectants in the rat C58 cell line.
Mutation of the conserved cysteine residues to serine pre-
vented cell surface expression at 37 C, as determined by ﬂow
cytometry (Fig. 1B). Pulse-chase and immunoprecipitation
experiments also revealed that, whilst the wildtype A2 acquired
partial endoglycosidase H (endo H) resistance, the mutants re-
mained fully sensitive to endo H digestion during a three-hour
chase period, indicating a failure to exit from the ER (Fig. 1C).
Cell surface biotinylation and immunoprecipitation also re-
vealed no detectable surface expression (data not shown). Sev-
eral of the mutants, A2.C164S for example, displayed clear
evidence of ER degradation after 3 h chase.
When extended pulse-chase experiments were performed at
reduced temperature (26 C), signiﬁcant acquisition of endoeduced temperature. (A) Location of the conserved cysteine residues in
lls expressing wildtype or mutant A2 molecules were analysed by ﬂow
anti-mouse IgG alone. Solid line indicates BB7.2. Filled curves in the
molecules were immunoprecipitated at the indicated chase timepoints,
tant (-r) species are indicated. (D) Cells were radiolabelled and chased
ted cells were incubated overnight at 37 C or 26 C and then analysed
Fig. 2. ERp57 associates with A2 molecules lacking both conserved
cysteines in the a3 domain. C58 cells expressing wildtype A2 molecules,
or the double cysteine mutants A2.C101S-C164S and A2.C203S-C259S
were incubated overnight at the indicated temperatures of 37 C or
26 C, and then lysed, immunoprecipitated with anti-MHC class I
heavy chain and immunoblotted for ERp57, calnexin and MHC
class I.
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ing partial rescue of assembly and delivery to the cell surface
(Fig. 1D). Flow cytometry conﬁrmed surface expression
(Fig. 1E), correlating with the pulse-chase observations. Cell
surface biotinylation and immunoprecipitation conﬁrmed the
expression of B2m-associated A2 molecules at the cell surface
(not shown). Thus incubation at reduced temperature can par-
tially compensate for the lack of a conserved disulﬁde bond in
both the peptide-binding groove and the a3-domain.
3.2. Detection of ERp57-MHC class I intermediates
The ability of the cysteine mutant molecules to fold and be
delivered to the cell surface at reduced temperature led us toFig. 3. (A) ERp57 associates with A2 molecules lacking one of the two conser
cells, or cells expressing wildtype A2, or the single cyteine mutants A2.C101S
indicated temperatures and then lysed, immunoprecipitated with anti-MHC c
class I. (B) .220.B8 cells were lysed, immunoprecipitated with HC10, an
immunoblotting for ERp57.ask whether we could analyse ERp57-MHC class I interactions
in these cells. We generated C58 transfectant lines expressing
HLA-A2 cDNA mutants lacking either both cysteine residues
in the peptide-binding groove (annotated A2.C101S-C164S),
or in the a3 domain (A2.C203S-C259S). Anti-MHC I heavy
chain immunoprecipitations were performed on cells that
had been incubated overnight at 26 C or 37 C. Non-reduced
samples were immunoblotted for ERp57, which revealed the
presence of ERp57-class I heavy chain complexes in
A2.C203S-C259S cells, i.e. in the A2 molecule that still pos-
sessed cysteine residues in the peptide groove (Fig. 2). This
interaction was enhanced at reduced temperature. No interac-
tion was detected in cells expressing A2.C101S-C164S, suggest-
ing that ERp57 does not associate signiﬁcantly with the a3
domain cysteine residues. Further immunoblotting of the
immunoprecipitates revealed the presence of the chaperone
calnexin at similar levels in all immunoprecipitated samples.
3.3. ERp57 association with cysteine residues in the
peptide-binding groove
Based on the above ﬁndings, we next studied which of the
two conserved cysteine residues in the peptide groove were
capable of interacting with ERp57. We made use of the sin-
gle conserved cysteine mutants of A2 expressed in C58 cells.
As above, anti-MHC class I heavy chain immunoprecipita-
tion of cell lysates was performed and non-reduced samples
immunoblotted for ERp57, calnexin and MHC class I heavy
chain. As shown in Fig. 3A, ERp57-class I heavy chain com-
plexes were detected primarily in A2.C101S and A2.C164S
cells, and only very weakly in A2, A2.C203S and A2.C259S
cells. Furthermore, the diﬀerent relative gel mobilities of
the ERp57-A2.C101S and the ERp57-A2.C164S complexes
appear to correlate with the two main species detected in
ERp57-A2.C203S-C259S cells (Fig. 3A), suggesting that in
the double mutant A2.C203S-C259S cells, ERp57 can inter-
act with both peptide-groove cysteines. To conﬁrm that the
observed ERp57-MHC class I interactions were not due to
the xenogeneic expression of a human MHC class I molecule
in a rat cell line, we also studied the tapasin deﬁcient .220
cell line transfected with HLA-B8. Immunoprecipitationved cysteine residues in the peptide-binding groove. Untransfected C58
, A2.C164S, A2.C203S and A2.C259S, were incubated overnight at the
lass I heavy chain and immunoblotted for ERp57, calnexin and MHC
d reduced and non-reduced samples analysed by SDS–PAGE and
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vealed similar complexes to those observed in rat C58 cells
(Fig. 3B).4. Discussion
To assist the dissection of the early events in MHC class I
folding, in this study we have initiated an approach to deter-
mine which of the conserved cysteine residues in MHC class
I molecules interact with ERp57. Oxidoreductase-substrate
intermediates are often short-lived and constitute a relatively
small proportion of the protein population undergoing fold-
ing. Furthermore, to isolate ERp57-class I heavy chain inter-
mediates we have avoided the use of mAbs that depend on
the conformation of the class I molecule. Instead, our
approach has been to utilise an epitope tag inserted at the C-
terminus of the class I heavy chain, permitting isolation irre-
spective of folding status.
By removing both cysteine residues in either the peptide-
binding groove (C101S-C164S), or the a3-domain (C203S-
C259S) our data demonstrate that ERp57-class I heavy chain
complexes can be detected when the peptide-groove cysteines
are retained. In the single cysteine mutants the ERp57-class I
heavy chain interactions were detected when we disrupted
the normal disulﬁde bond formation in the peptide-binding
groove. The noted diﬀerences in gel mobility in the single
cysteine mutants (Fig. 3A), which correlate with the species
seen in the a3-domain (C203S-C259S) mutant (Fig. 2), suggest
considerable conformational diﬀerences exist between the
A2.C101S-ERp57 and A2.C164S-ERp57 species. However,
at this stage we cannot distinguish whether these diﬀerences re-
side in the MHC class I heavy chain or ERp57, although alter-
ations in the MHC class I heavy chain seem more likely. Taken
together our data point to ERp57 being able to interact with
the most membrane-distal region of MHC class I molecules,
the peptide-binding groove.
Calnexin and calreticulin interact with proteins through
their lectin-binding activity [20], with the crucial glycan site
on MHC class I molecules being asparagine at position 86, lo-
cated at the end of the peptide-binding groove on the a1 helix
[21,22]. From this location the extended calnexin/calreticulin
P-domain arm, which interacts with ERp57 at its tip [23],
would conceivably allow ERp57 access to the nascent pep-
tide-binding groove.
In ERp57 deﬁcient B cells there appears to be no gross defect
in the redox state of MHC class I molecules [15]. Such data
indicate that oxidation of MHC class I molecules during
assembly can occur in the absence of ERp57, and indeed recent
data ascribe this function to PDI [9]. However, peptide optimi-
sation is disrupted in such circumstances. Therefore, ERp57
may indeed have a direct role, in combination with PDI, in
MHC class I assembly.
In the experiments reported here we did not set out primarily
to determine the disulﬁde interactions occurring within the
PLC, and for this reason we utilised a detergent that would
not preserve the PLC, but would be able to preserve interac-
tions with calnexin. Thus our observations may relate to early
stages of MHC class I assembly. Experiments are now under-
way to determine the relative contributions of ERp57 and PDI
in the PLC.Acknowledgements: A.N.A. is funded by an Arthritis Research Cam-
paign UK Fellowship (Grant No. 15293). S.L. is funded by the Mait-
land-Ramsay Ph.D. studentship. S.G.S. is funded by a Portugese
Foundation for Science and Technology Fellowship (SFRH/BPD/
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